Herein we detected significantly higher frequencies of CD8+ T cells in tumors of mice treated with Tasquinimod when compared to untreated tumor-bearing mice, which only showed CD8+ T cells in the marginal zones of the tumor (Figure 7A). This evidence concerns the gene CD8A and neoplasm.